Phase 1/2 Study of ZK-Epothilone (ZK-Epo; ZK-219477) in Combination With Carboplatin in Patients With Platinum-sensitive Recurrent Ovarian Cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Carboplatin; Sagopilone
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Bayer HealthCare Pharmaceuticals Inc.; Berlex Inc
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2009 Planned end date changed from 1 Sep 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
- 12 Nov 2006 New trial record.